Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design. - Eleonora Gianti; Troy E. Messick; Paul M. Lieberman; Randy J. Zauhar (J. Comput. Aided Mol. Des., 2016)